Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessCorrection: Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer
-
Article
Open AccessEpigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer
Human epidermal growth factor receptor 2 (HER2)-amplified breast cancers are treated using targeted antibodies and kinase inhibitors, but resistance to these therapies leads to systemic tumor recurrence of metast...